Intellectual Property Magazine
ERS Genomics licenses out CRISPR portfolio
Ben Wodecki
CRISPR giants ERS Genomics has broadened its Cas9 patentportfolio by signing a licensing agreement with biologics firm, Axxam.
CRISPR giants ERS Genomics has broadened its Cas9 patentportfolio by signing a licensing agreement with biologics firm, Axxam.